Inari Medical NARI

$ 49.66 1.35%

Quarterly report 2024-Q3
added 10-28-2024

Inari Medical Balance Sheet 2011-2024 | NARI

Annual Balance Sheet Inari Medical

	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	-27.9 M	-63.5 M	-	-4.16 M	-12 M	-	-	-	-	-	-	-
Long Term Debt	31 M	28.4 M	-	19.5 M	9.84 M	-	-	-	-	-	-	-
Long Term Debt Current	1.31 M	802 K	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	74.8 M	64.2 M	-	-	-	-	-	-	-
Total Current Liabilities	56.2 M	42.5 M	13.8 M	-	-	-	-	-	-	-	-	-
Total Liabilities	87.2 M	72.3 M	13.8 M	83.7 M	66.3 M	-	-	-	-	-	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-46.8 M	-17.6 M	-27.4 M	-41.2 M	-40.1 M	-	-	-	-	-	-	-
Total Assets	504 M	312 M	214 M	44.5 M	26.9 M	-	-	-	-	-	-	-
Cash and Cash Equivalents	60.2 M	92.8 M	115 M	24 M	21.9 M	-	-	-	-	-	-	-
Book Value	417 M	239 M	200 M	-39.1 M	-39.4 M	-	-	-	-	-	-	-
Total Shareholders Equity	417 M	239 M	200 M	-39.1 M	-39.4 M	-	-	-	-	-	-	-

All numbers in USD currency

Quarterly Balance Sheet Inari Medical

	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	31.1 M	31.2 M	29.8 M	30.4 M	30.6 M	31.1 M	31.5 M	31 M	30.4 M	-	28.3 M	28.4 M	28.5 M	156 K	351 K	-	-	29.6 M	-	19.5 M	19.5 M	19.5 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	262 M	249 M	215 M	209 M	96.7 M	89.3 M	79.8 M	87.2 M	72.7 M	-	65.3 M	72.3 M	58.1 M	31.7 M	21 M	13.8 M	13.8 M	13.8 M	13.8 M	29.5 M	29.5 M	29.5 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-122 M	-104 M	-72.7 M	-48.5 M	-43.8 M	-47 M	-49.1 M	-46.8 M	-41.1 M	-	-20.7 M	-17.6 M	-18.7 M	-15.9 M	-20 M	-27.4 M	-27.4 M	-27.4 M	-27.4 M	-41.2 M	-41.2 M	-41.2 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	697 M	673 M	662 M	674 M	549 M	525 M	507 M	504 M	488 M	-	484 M	312 M	292 M	254 M	235 M	214 M	214 M	214 M	214 M	44.5 M	44.5 M	44.5 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash and Cash Equivalents	41.1 M	70.1 M	66.7 M	38.6 M	89.2 M	57.8 M	56.6 M	60.2 M	83.5 M	79.7 M	187 M	92.8 M	81.2 M	91.3 M	103 M	114 M	114 M	114 M	114 M	23.6 M	23.6 M	23.6 M	-	21.9 M	-	-	-	6.77 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Book Value	435 M	424 M	447 M	465 M	452 M	436 M	427 M	417 M	415 M	-	419 M	239 M	234 M	222 M	214 M	200 M	200 M	200 M	200 M	15 M	15 M	15 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Shareholders Equity	435 M	424 M	447 M	465 M	452 M	436 M	427 M	417 M	415 M	414 M	419 M	239 M	234 M	222 M	214 M	200 M	200 M	200 M	200 M	-39.1 M	-39.1 M	-39.1 M	-40.2 M	-39.4 M	-	-	-	-29.5 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency